News Posts List
Metastatic Tumor in the Colon from Renal Cell Carcinoma
06/01/2010
A 74-year-old male is admitted to hospital for dyspnoea. Findings from chest x-ray, computed tomography, and colonoscopy are described; images provided.
Sunscreen Products Linked to Kidney Cancer
05/31/2010
. . . chemicals poured into sunscreen products are equally dubious. They include:TEA, DEA, MEA (tri-, di- and mono- ethaloamines). These chemicals can cause liver and kidney cancer.
Seattle Genetics Leads the Way in Next Generation Antibody Technologies
05/31/2010
Seattle Genetics has two proprietary ADCs in the clinic, one in late stage trials for Hodgkins Lymphoma and a second in early stage trials for non-Hodgkins Lymphoma and Renal Cell Carcinoma.
Pioneering cancer drug treatment goes on trial
05/31/2010
A CANCER patient from Yorkshire has become the first in the world to trial a new drug experts hope will become part of a new generation of treatments against the disease.
Readers share famous encounters
05/30/2010
Not only did Bob meet Elvis Presley, he also ended up with a bottle of the King's Vaseline Hair Tonic. Inspired by this anecdote, I asked readers to send me their accounts of encounters with the famous.
Cancer patient 'abandoned' by drug refusal
05/30/2010
A CANCER patient last night said he felt "completely abandoned" after health chiefs refused to pay for a new drug which could prolong his life.
Targeted agents for renal cell carcinoma
05/30/2010
Proposals to use these agents as neoadjuvant therapy have generated significant controversy, Dr. Van Poppel said.
Antibody diagnostic appears specific for clear cell renal cell carcinoma
05/30/2010
Agent shows high preoperative sensitivity, specificity, data indicate.
Cancer Vaccine Research Is Coming To Fruition
05/28/2010
The launch of Sanofi Pasteur MSD's Gardasil and GSK's Cervarix has propelled cancer vaccines from research obscurity to a key area of commercial and clinical interest. But can the sector capitalise on these gains and really fulfil its promise?
Imaging of advanced renal cell carcinoma
05/27/2010
MDCT represents the diagnostic mainstay for the detection and staging of RCC. In the wake of new systemic therapies for advanced RCC, including angiogenesis inhibitor drugs, monitoring treatment response may become a new task for crosssectional imaging.
News Feed